A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials of DHEA Treatment Effects on Quality of Life in Women with Adrenal Insufficiency
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
CONTEXT: Women with primary or secondary adrenal insufficiency report a decreased health-related quality of life (HRQOL) despite traditional adrenal replacement therapy. Dehydroepiandrosterone (DHEA) has been studied as an agent to improve HRQOL in these patients. OBJECTIVE: We sought to conduct a systematic review and meta-analysis of randomized controlled trials of DHEA effects on HRQOL in women with adrenal insufficiency. DATA SOURCES: We searched electronic databases (MEDLINE, EMBASE, Cochrane CENTRAL, Web of Science, CINAHL, and PsycInfo) and reference lists of eligible studies through July 2008. STUDY SELECTION: Eligible trials randomly assigned women with primary or secondary adrenal insufficiency to either DHEA or control and measured the effect of treatment on HRQOL. DATA EXTRACTION: Reviewers working independently and in duplicate assessed the methodological quality of trials and collected data on patient characteristics, interventions, and outcomes. DATA SYNTHESIS: We found 10 eligible trials that measured HRQOL and depression, anxiety, and sexual function. Random-effects meta-analysis showed a small improvement in HRQOL in women treated with DHEA compared with placebo [effect size of 0.21; 95% confidence interval, 0.08 to 0.33; inconsistency (I(2)) = 32%]. There was a small beneficial effect of DHEA on depression; effects on anxiety and sexual well-being were also small and not statistically significant. CONCLUSIONS: DHEA may improve, in a small and perhaps trivial manner, HRQOL and depression in women with adrenal insufficiency. There was no significant effect of DHEA on anxiety and sexual well-being. The evidence appears insufficient to support the routine use of DHEA in women with adrenal insufficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review and metaanalysis of randomized placebo controls of DHEA treatment have not shown any substantial clinical benefit, suggesting that the current evidence is insufficient to support routine use of DHEA in women with adrenal insufficiency (117).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [117]
In the citing paper
“A systematic review and metaanalysis of randomized placebo controls of DHEA treatment have not shown any substantial clinical benefit, suggesting that the current evidence is insufficient to support routine use of DHEA in women with adrenal insufficiency (117).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [117]
Citations
Cites
1 retracted
Dehydroepiandrosterone (DHEA) supplementation for cognitive function.
Huppert, F., & Van Niekerk, J. (2001) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000304 · Cited by 88
RetractedStatistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Users' guides to the medical literature : a manual for evidence-based clinical practice
Guyatt, G. H., Rennie, D., Meade, M. O., & Cook, D. J. (2002) · Cited by 1,196
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Hunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7022 · Cited by 386 · cited 3×
“Arlt, 1999 (2) 24 42 Primary and secondary 50 4 Normal Bilger, 2005 (11) 5 19 Secondary 50 6 Normal Hunt, 2000 (3) 24 40 Primary 50 3 Normal Libe, 2004 (17) 7 45 Primary and secondary 50 4 Normal Lovas, 2003 (4) 36 46 Primary and secondary 25 9 Most reached normal Johannsson, 2002 (5) 38 51 Secondary 20 ( 45 yr old) o…”
BackgroundThe n-of-1 Randomized Controlled Trial: Clinical Usefulness: Our Three-Year Experience
Guyatt, G. H., Keller, J. L., Jaeschke, R., Rosenbloom, D., Adachi, J. D., & Newhouse, M. T. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-4-293 · Cited by 320
Research works printed but not linked: 1
- Huppert, 2000, Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being, Cochrane Database Syst Rev
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
“A systematic review and metaanalysis of randomized placebo controls of DHEA treatment have not shown any substantial clinical benefit, suggesting that the current evidence is insufficient to support routine use of DHEA in women with adrenal insufficiency (117).”
Background2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Husebye, E. S., Pearce, S. H., Krone, N. P., & Kämpe, O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00136-7 · Cited by 378
Androgen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline
Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2260 · Cited by 363
“In 2009, a meta-analysis of 10 studies concluded that DHEA therapy in adrenal insufficiency may result in small improvements in health-related quality of life and depression, but it had no effects on anxiety or sexual well-being (142).”
Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660290 · Cited by 337
“Dehydroepiandrosterone (DHEA) is a hormone produced by the adrenal cortex, which is subsequently converted to sex hormones in the body.(82) It plays a role in modulating neuroendocrine and immune homeostasis and influences monoaminergic and glutaminergic neurotransmission.”
BackgroundDehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME)
Traish, A. M., Kang, H. P., Saad, F., & Guay, A. T. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02523.x · Cited by 234
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Dehydroepiandrosterone (DHEA): Hypes and Hopes
Rutkowski, K., Sowa, P., Rutkowska-Talipska, J., Kuryliszyn-Moskal, A., & Rutkowski, R. (2014) · Drugs · doi:10.1007/s40265-014-0259-8 · Cited by 216
“[37] confirmed a small but clinically trivial improvement in health-related quality of life, depression, anxiety and sexual function scores in elderly women with adrenal insufficiency treated with oral DHEA.”
BackgroundMaggi, M., Buvat, J., Corona, G., Guay, A., & Torres, L. O. (2013) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02735.x · Cited by 157
Adrenal insufficiency: etiology, diagnosis and treatment
Neary, N., & Nieman, L. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328338f608 · Cited by 140
Sexual well-being after menopause: An International Menopause Society White Paper
Simon, J. A., Davis, S. R., Althof, S. E., Chedraui, P., Clayton, A. H., Kingsberg, S. A., Nappi, R. E., Parish, S. J., & Wolfman, W. (2018) · Climacteric · doi:10.1080/13697137.2018.1482647 · Cited by 127
Addison disease: early detection and treatment principles.
Michels, A. W., & Michels, N. (2014) · PubMed · Cited by 159
Grossman, A., Johannsson, G., Quinkler, M., & Zelissen, P. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0450 · Cited by 119
Fleseriu, M., Christ‐Crain, M., Langlois, F., Gadelha, M. R., & Melmed, S. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00342-8 · Cited by 141
Corona, G., Rastrelli, G., Giagulli, V. A., Sila, A., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1358 · Cited by 105
“A systematic review of DHEA dosing in elderly women populations, without adrenal insufficiency, concluded that DHEA supplementation plays a marginal role in improving overall well-being (8).”
BackgroundClinical Use and Molecular Action of Corticosteroids in the Pediatric Age
Ferrara, G., Petrillo, M. G., Giani, T., Marrani, E., Filippeschi, C., Oranges, T., Simonini, G., & Cimaz, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020444 · Cited by 115
“DHEA treatment may have a role in pubertal females with adrenal insufficiency [122,123].”
BackgroundMethlie, P., Hustad, S., Kellman, R., Almås, B., Erichsen, M. M., Husebye, E. S., & Løvås, K. (2013) · Endocrine Connections · doi:10.1530/ec-13-0023 · Cited by 92
DHEA for postmenopausal women: A review of the evidence
Panjari, M., & Davis, S. R. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.12.017 · Cited by 97
A Practitioner's Toolkit for Managing the Menopause
Jane, F., & Davis, S. R. (2014) · Climacteric · doi:10.3109/13697137.2014.929651 · Cited by 97
Opioid-Induced Adrenal Insufficiency
Donegan, D., & Bancos, I. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.010 · Cited by 78
Santoro, N. F., Braunstein, G. D., Butts, C. L., Martin, K. A., McDermott, M., & Pinkerton, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1271 · Cited by 83
Adrenal Insufficiency in Adults: A Review
Vaidya, A., Findling, J., & Bancos, I. (2025) · JAMA · doi:10.1001/jama.2025.5485 · Cited by 75
Bensing, S., Hulting, A.-L., Husebye, E. S., Kämpe, O., & Løvås, K. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1242 · Cited by 67
Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., et al. (2018) · Focus · doi:10.1176/appi.focus.16106 · Cited by 65
“Dehydroepiandrosterone (DHEA) is a hormone produced by the adrenal cortex, which is subsequently converted to sex hormones in the body.(82) It plays a role in modulating neuroendocrine and immune homeostasis and influences monoaminergic and glutaminergic neurotransmission.”
BackgroundAlexandraki, K., & Grossman, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122153 · Cited by 62
“The use of a continuous subcutaneous HC infusion (CSHI) has been reported in patients with PAI, demonstrating a more physiological cortisol circadian rhythm, a normalisation of morning ACTH and restoration of nocturnal serum cortisol levels, along with a better QoL profile compared to conventional HC doses [1,49].”
ResultInfluentialAdrenal Cortical Insufficiency
Quinkler, M. O., Beuschlein, F., Hahner, S., Meyer, G., Schöfl, C., & Stalla, G. K. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0882 · Cited by 82
Addison Disease in Adults: Diagnosis and Management
Chakera, A. J., & Vaidya, B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.017 · Cited by 72
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Worsley, R., Santoro, N. F., Miller, K. K., Parish, S. J., & Davis, S. R. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.014 · Cited by 55
Davis, S. R. (2024) · New England Journal of Medicine · doi:10.1056/nejmcp2313307 · Cited by 65
Associations between androgens and sexual function in premenopausal women: a cross-sectional study
Zheng, J., Islam, R. M., Skiba, M. A., Bell, R. J., & Davis, S. R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30239-4 · Cited by 50
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Androgens in postmenopausal women: a review
Shifren, J. L., & Davis, S. R. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000903 · Cited by 48
Novel Insight into Etiology, Diagnosis and Management of Primary Adrenal Insufficiency
Malikova, J., & Flück, C. E. (2014) · Hormone Research in Paediatrics · doi:10.1159/000363107 · Cited by 40
Secondary Adrenal Insufficiency: Recent Updates and New Directions for Diagnosis and Management
Gruber, L., & Bancos, I. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.09.011 · Cited by 45
What is the best long‐term management strategy for patients with primary adrenal insufficiency?
Quinkler, M., & Hahner, S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04103.x · Cited by 50
Should Dehydroepiandrosterone Be Administered to Women?
Wierman, M. E., & Kiseljak‐Vassiliades, K. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac130 · Cited by 37
Health-related quality of life in primary and secondary adrenal insufficiency
Aulinas, A., & Webb, S. M. (2014) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.963559 · Cited by 32
“DHEA-S replacement should not be used routinely in patients with AI according to the evidence of a meta-analysis of randomized placebo-controlled trials of DHEA-S that measured HRQoL, depression, anxiety and sexual function [36].”
MethodResultDiagnosis and management of pediatric adrenal insufficiency
Uçar, A., Baş, F., & Saka, N. (2016) · World Journal of Pediatrics · doi:10.1007/s12519-016-0018-x · Cited by 40
Latent Adrenal Insufficiency: Concept, Clues to Detection, and Diagnosis
Yamamoto, T. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0114 · Cited by 36
Weiss, R. V., Hohl, A., Athayde, A. L., Pardini, D., Gomes, L. G., de Oliveira, M., Meirelles, R. M. R., Clapauch, R., & Spritzer, P. M. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000152 · Cited by 35
National consensus on the management of patients in menopause
Вільєрс, Т. Д., Татарчук, Т. Ф., Авраменко, Н. В., Булавенко, О. В., Габаль, В. А., Burlaka, O., Ганжий, І. Ю., Геник, Н. І., Грищенко, О. В., Громова, А. М., et al. (2016) · Reproductive Endocrinology · doi:10.18370/2309-4117.2016.27.8-25 · Cited by 30
Bentley, C., Hazeldine, J., Greig, C. A., Lord, J. M., & Foster, M. (2019) · Burns & Trauma · doi:10.1186/s41038-019-0158-z · Cited by 32
“those with moderate depression [118] and psychiatric disorders [119–121] and adrenal insufficient women [122] has shown potential for mental health.”
BackgroundOpioid induced adrenal insufficiency: what is new?
Donegan, D. M. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000474 · Cited by 24
Hamza, R. Z., Al-Malki, N. A., Alharthi, S., Alharthy, S. A., Albogami, B., & El‐Megharbel, S. M. (2022) · Antioxidants · doi:10.3390/antiox11071229 · Cited by 23
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00020-1 · Cited by 24
Petersen, K. S., Rushworth, R. L., Clifton, P. M., & Torpy, D. J. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0058-6 · Cited by 23
A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency
Charoensri, S., & Auchus, R. J. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1894 · Cited by 27
“Adrenal androgen replacement with DHEA at a daily dose ranging from 10 to 25 mg might be beneficial in improving libido and mental well-being, both via conversion to testosterone and possibly through direct effects as well [8,59].”
BackgroundGroup 4: Replacement therapy for adrenal insufficiency
Castinetti, F., Guignat, L., Bouvattier, C. M., Samara‐Boustani, D., & Reznik, Y. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.10.007 · Cited by 20
Qin, Y., Santos, H. O., Khani, V., Tan, S. C., & Zhi, Y. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.015 · Cited by 22
Walsh, T. P., Baird, G. L., Atalay, M. K., Agarwal, S., Arcuri, D., Klinger, J. R., Mullin, C. J., Morreo, H., Normandin, B., Shiva, S., et al. (2021) · Pulmonary Circulation · doi:10.1177/2045894021989554 · Cited by 21
“Although the results of RCTs of DHEA for these indications have been mixed, no serious side effects were reported in RCTs including >1200 patients; reversible mild androgenic side effects (oily skin, hirsutism, acne) were noted in some studies.(28,34,35) While DHEA is included in some dietary supplements, the U.”
Addisonian crisis in a young man with atypical anorexia nervosa
Allolio, B., Lang, K., & Hahner, S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.211 · Cited by 19
“0 mg per day as a single morning dose) may be beneficial in patients with Addison disease whose well-being is impaired on standard replacement with glucocorticoids and mineralocorticoids”
BackgroundZimmerman, Y., Foidart, J. M., Pintiaux, A., Minon, J., Fauser, B. C. J. M., Cobey, K. D., & Bennink, H. J. T. C. (2014) · Contraception · doi:10.1016/j.contraception.2014.11.008 · Cited by 16
Is DHEA replacement beneficial in chronic adrenal failure?
Lang, K., Burger‐Stritt, S., & Hahner, S. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.007 · Cited by 17
Rabijewski, M., Papierska, L., Bińkowska, M., Maksym, R., Jankowska, K. K., Skrzypulec‐Plinta, V., & Zgliczyński, W. (2020) · Ginekologia Polska · doi:10.5603/gp.2020.0091 · Cited by 20
“No serious adverse effects have been ever reported [35, 63, 64].”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Bitencourt, M. R., Batista, R. L., Biscotto, I. P., & Carvalho, L. R. S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000493 · Cited by 16
“In the same study, the benefits related to anxiety and libido were not statistically significant (64).”
BackgroundZimmerman, Y., Foidart, J. M., Pintiaux, A., Minon, J., Fauser, B. C. J. M., Cobey, K. D., & Bennink, H. J. T. C. (2014) · Contraception · doi:10.1016/j.contraception.2014.11.002 · Cited by 16
“In this study, the daily co-administration of 50 mg DHEA did not give rise to safety concerns, as supported by data from the literature [54-61].”
ResultEndocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic
Barnabei, A., Senes, P., Scoppola, A., Chiefari, A., Iannantuono, G. M., Appetecchia, M., & Torino, F. (2022) · Cancers · doi:10.3390/cancers14030593 · Cited by 14
Impaired attention in patients with adrenal insufficiency – Impact of unphysiological therapy
Blacha, A. K., Rahvar, A., Flitsch, J., van de Loo, I., Kropp, P. A., & Harbeck, B. (2021) · Steroids · doi:10.1016/j.steroids.2020.108788 · Cited by 16
Primary adrenal insufficiency in adults: When to suspect, how to diagnose and manage
Lundholm, M. D., Ambalavanan, J., & Rao, P. P. R. (2024) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.91a.23072 · Cited by 14
Blacha, A. K., Kropp, P. A., Rahvar, A., Flitsch, J., van de Loo, I., & Harbeck, B. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02731-y · Cited by 12
“Co-medication with dehydroepiandrosteron (DHEA) may have positive effects on mood and fatigue [16, 17], but as yet, there are no hard criteria for use.”
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00020-4 · Cited by 17
Burger‐Stritt, S., Pulzer, A., & Hahner, S. (2016) · Frontiers of hormone research · doi:10.1159/000443918 · Cited by 16
Pathophysiology and Medical Management of Hypoactive Sexual Desire Disorder
Clayton, A. H., & Vignozzi, L. (2018) · Wiley eBooks · doi:10.1002/9781119266136.ch6 · Cited by 15
Quinkler, M. O. (2012) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-012-0112-3 · Cited by 22
Androgen deficiency in hypopituitary women: its consequences and management
Espósito, D., Tivesten, Å., Olivius, C., Ragnarsson, Ó., & Johannsson, G. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09873-1 · Cited by 9
“…10 placebo-controlled trials assessing the effects of DHEA treatment in women with adrenal insufficiency showed that DHEA therapy led to a slight improvement in quality of life and a reduction in the rate of depression, but no significant effects on anxiety or sexual well-being were observed [71].”
BackgroundMorbus Addison: Primäre Nebenniereninsuffizienz
Pulzer, A., Burger‐Stritt, S., & Hahner, S. (2016) · Der Internist · doi:10.1007/s00108-016-0054-6 · Cited by 28
“Die Effekte sind meist nur moderat, interindividuell jedoch sehr variabel [22].”
Female Sexual Dysfunction in Primary Adrenal Insufficiency
Zamponi, V., Lardo, P., Maggio, R., Simonini, C., Mazzilli, R., Faggiano, A., Pugliese, G., & Stigliano, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132767 · Cited by 9
Donald, D. M., McDonnell, T., O’Reilly, M., & Sherlock, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09897-7 · Cited by 8
“A meta-analysis reported DHEA led to a modest improvement in quality of life but not sexual functioning in women with primary adrenal insufficiency [ 33].”
BackgroundEnfermedades de las glándulas suprarrenales
Rabinovich, I. H., & de Victoria, E. O. M. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-595-0.00020-x · Cited by 7
Androgen therapy for women after menopause
Marko, K. I., & Simon, J. A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101592 · Cited by 12
Development and assessment of a low-health-literacy, pictographic adrenal insufficiency action plan
Reeves, P. T., Packett, A. C., Burklow, C. S., Echelmeyer, S., & Larson, N. S. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0541 · Cited by 8
“The chronic morbidity of AI can lead to downstream negative effects of patients’ healthcare-related quality of life (HRQoL) [10, 11].”
BackgroundFertility and pregnancy in adrenal insufficiency
Green, D., Dineen, R., O’Reilly, M., & Sherlock, M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0088 · Cited by 13
1. Early Diagnosis and Treatment of Adrenal Insufficiency
Kawate, H., & Takayanagi, R. (2014) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.103.878 · Cited by 6
Sandoughi, M., Kaykhaei, M. A., Langarizadeh, E., & Dashipour, A. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13975 · Cited by 6
Bertholf, R. L., Jialal, I., & Winter, W. E. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00054-8 · Cited by 5
Clinical features, investigation, and management of Addison's disease
Dong, J., Hahner, S., Bancos, I., & Tomlinson, J. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00393-6 · Cited by 5
Quality of Life in Patients with Adrenal Insufficiency
Li, D. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.04.003 · Cited by 6
Diagnosis and Treatment of Adrenal Insufficiency
Yoo, S. J., & Jeong, H. (2012) · Hanyang Medical Reviews · doi:10.7599/hmr.2012.32.4.203 · Cited by 5
“증상을 보이는 환자 일부에 도움이 될 것으로 추정되지만 생리적인 역할이 아직 명백하지 않아 논란의 여지가 있다[22,23].”
Case 16-2013: A 12-Year-Old Girl with Irritability, Hypersomnia, and Somatic Symptoms
Bender, S. L., Sherry, N., & Masia, R. (2013) · New England Journal of Medicine · doi:10.1056/nejmcpc1208145 · Cited by 7
Epidemiology, quality of life and complications of primary adrenal insufficiency: a review
Bensing, S., & Husebye, E. S. (2016) · Cited by 5
Glucocorticoid replacement therapies: past, present and future
Liew, S.-Y., Akker, S. A., Guasti, L., & Pittaway, J. F. H. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.011 · Cited by 7
Moyad, M. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-23422-9_7 · Cited by 5
Sanders, R., Walsh, T. P., Baird, G. L., Atalay, M. K., Agarwal, S., Arcuri, D., Klinger, J. R., Mullin, C. J., Simmons, J., Singh, N., et al. (2026) · Annals of the American Thoracic Society · doi:10.1093/annalsats/aaoag195 · Cited by 5
Stergianos, S., Spelman, T. D., Eriksson, D., Öster, S., Björnsdóttir, S., Kämpe, O., Skov, J., & Bensing, S. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20085 · Cited by 5
Sierra, J. F. G., Seco‐Calvo, J., Arribalzaga, S., Díez, R., López, C., Fernández, N., Garcia, J. J., Diez, M. J., de la Puente, R., Sierra, M., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1305080 · Cited by 6
Bentley, C., Potter, C., Yakoub, K. M., Brock, K., Homer, V., Toman, E., TAYLOR, A. E. R., Shaheen, F., Gilligan, L. C., Athwal, A. K., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-040823 · Cited by 5
Use of androgens at different stages of life: reproductive period
Nácul, A. P., Rezende, G. P., Yela, D. A., Maranhão, T. M. D. O., Costa, L. O. B. F., dos Reis, F. M., Maciel, G. A. R., Damásio, L. C. V. D. C., Silva, A. C. J. D. S. R. E., Lopes, V. M., et al. (2021) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1740610 · Cited by 6
“Dehydroepiandrosterone is a dietary supplement without regulatory control and robust evidence to indicate its routine use in adrenal insufficiency.(27) In practice, androgen replacement with DHEA is sometimes used for women with symptoms of androgen deficiency and low plasma levels of DHEA, with starting doses between…”
BackgroundSexual Dysfunction in Women with Type 2 Diabetes Mellitus: An Observational Study
Gupta, M., Shukla, R., Verma, S., & Kalhan, A. (2022) · Journal of Diabetology · doi:10.4103/jod.jod_108_21 · Cited by 7
Varlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Dehydroepiandrosterone and androstenedione
Allolio, B., Arlt, W., & Hahner, S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.021 · Cited by 5
Mischley, L. K., Nicolai, P. J., & Gaby, A. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00085-7 · Cited by 4
Zimmerman, Y., Bennink, H. J. T. C., Wouters, W., Ebes, F., & Fauser, B. C. J. M. (2013) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2013.822061 · Cited by 3
Androgen deficiency in women with adrenal insufficiency. Dehydroepiandrosterone. Review
Nuralieva, N. F., Yukina, M. Y., Troshina, E. A., & Platonova, N. M. (2018) · GYNECOLOGY · doi:10.26442/2079-5696_2018.4.35-39 · Cited by 3
Dehydroepiandrosterone sulfate levels predict weight gain in women with anorexia nervosa
Kimball, A., Colling, C., Haines, M. S., Meenaghan, E. M., Eddy, K. T., Misra, M., & Miller, K. K. (2022) · International Journal of Eating Disorders · doi:10.1002/eat.23767 · Cited by 4
Blanco, M. C., Vidal-Suárez, Á., & Martín-Portugués, A. B. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.10.010 · Cited by 4
Hughes, I. A., & Chatterjee, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00105-0 · Cited by 3
Metadata
- Authors
- Alkatib, A. A., Cosma, M., Elamin, M. B., Erickson, D., Swiglo, B. A., Erwin, P. J., & Montori, V. M.
- Affiliations
- Mayo Clinic (US)
- Knowledge and Encounter Research Unit (A.A.A., M.C., M.B.E., D.E., B.A.S., P.J.E., V.M.M.), Mayo Clinic, Rochester, Minnesota 55905
- ORCID
- Erickson, Dana
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-10-01
- Volume
- 94
- Issue
- 10
- Pages
- 3676-3681
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1995511987
- Semantic Scholar
- 9fc991e4fd15b00453fca84c3a545ade4c4a8a3c
- Cited by
- 147
- References
- 23
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 9 · 2019: 7 · 2018: 7 · 2017: 2 · 2016: 16 · 2015: 7 · 2014: 15 · 2013: 13 · 2012: 8
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- dehydroepiandrosterone, adrenal insufficiency, health-related quality of life, women, depression, anxiety, sexual function, Addison's disease, secondary adrenal insufficiency
- MeSH terms
- Adrenal Insufficiency, Anxiety, Dehydroepiandrosterone, Depression, Health Status, Humans, Quality of Life, Research Design, Sexual Behavior, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.